BioLife Solutions BLFS Stock issued as consideration for SciSafe earnout
Stock issued as consideration for SciSafe earnout at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept blfs:StockIssuedAsConsiderationForEarnout.
The official record: BioLife Solutions’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's stock issued as consideration for scisafe earnout.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's stock issued as consideration for scisafe earnout?
- BioLife Solutions (BLFS) reported stock issued as consideration for scisafe earnout of $0 in Q4 2025.
- What is the long-term trend for BioLife Solutions's stock issued as consideration for scisafe earnout?
- Over 3 years (2022 to 2025), BioLife Solutions's stock issued as consideration for scisafe earnout has grown at a -100.0% compound annual growth rate (CAGR), from $817K to $0.
- What does stock issued as consideration for scisafe earnout mean?
- Represents the value of equity instruments issued to satisfy contingent payment obligations related to previous business acquisitions. This metric highlights the use of stock-based compensation to settle purchase price adjustments, which preserves cash but results in shareholder dilution. It is a key indicator of the company's historical acquisition strategy and the long-term cost of integrating acquired entities.